Analyst Concall
PI Ind working on integrated service provider strategy
This story was originally published at 18:18 IST on 13 August 2025
Register to read our real-time news.Informist, Wednesday, Aug. 13, 2025
--PI Ind: Looking at inorganic opportunities currently
--CONTEXT: Comments from PI Industries' mgmt in post-earnings investors concall
--PI Ind: Sees revenue from pharma ops rising 75% in FY26
--PI Ind: Will invest INR 7 billion-INR 8 billion as capex in FY26
--PI Ind: Working on 10 electronic-chemicals project currently
--PI Ind: Working towards providing integrated services to pharma cos
By Avishek Rakshit & Gopika Balasubramanium
KOLKATA/MUMBAI – PI Industries Ltd., which is working on increasing its play in the pharmaceutical chemicals sector, is laying the foundations to emerge as an integrated service provider to pharma companies, a top company official said on Wednesday. "At the present moment, we are building a foundation. We are building credibility in the market and our strategic focus is to move to the CRDMO play. And I would say that we are pretty happy with the progress that we've made in that area," the official told sector analysts at a post-earnings conference call.
In the chemicals sector, CRDMO refers to a contract, research, development, and manufacturing organisation which provides integrated services and solutions to companies in the pharma and biotechnology fields. According to the official, this strategic shift in the company's positioning will take some time as the gestation period is quite high.
"It is building the right customer base. A lot of effort has been put in by the team. And given the external dynamics, and when the environment settles, we see this could turn into a longer-term, as a three- to four-year scenario, to drive the positivity," the official said.
PI Industries is ambitiously targeting a 75% top-line growth from its pharmaceutical chemicals business in the current financial year and is also bullish on developing the electronics chemicals vertical as a key future growth driver.
"We have done five to seven products in that area (electronics chemicals), and I do see a very good opportunity coming this year, and we see this to become a good segment in the next four to five years for us," the official said.
The company is engaging with global clients and is actively working on around 10 electronics chemicals projects, which have the potential to become major revenue drivers in the medium-term, a second senior company official said. At the same time, PI Industries is looking at inorganic opportunities to drive growth and expansion and has targeted to invest INR 7 billion-INR 8 billion as capex in the current financial year.
PI Industries said the imposition of steep tariffs by the Trump administration in the US on several countries has created uncertainty, but the company has not faced any challenges till now. "There is no clarity on the implication of tariffs, but at present, it's not applicable. And as you know, the tariff scenario is quite a confused one. So, from the present, we don't see any challenges," the company official said.
PI Industries has operations in over 40 countries across Asia, Europe, North America, and South America, with 10 overseas offices and six manufacturing sites outside India.
Wednesday, shares of PI Industries closed at INR 3772.70 on the National Stock Exchange, down 1.7% from the previous close. The company declared its June quarter earnings post-market hours Tuesday. End
Edited by Saji George Titus
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd by NSE Data & Analytics Ltd, a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
